Stericycle, Inc. (NASDAQ:SRCL) provides regulated and compliance solutions. The firm primarily serves the healthcare industry in the United States and Europe. On March 23, RBC Capital analyst Sean Dodge kept an Outperform rating on the stock with a price target of $82, naming the stock as the "New Top Idea for 2022" in a bullish investor note that highlighted the "sustained organic revenue growth and margin expansion" for the firm that were offsetting near-term risks.
Stericycle, Inc. (NASDAQ:SRCL) shares have pulled back in the past few months and now seem attractively valued, per market experts like Dodge, given the capital allocation initiatives that the waste management firm has undertaken in relation to debt reduction and business or asset sales.
At the end of the fourth quarter of 2021, 16 hedge funds in the database of Insider Monkey held stakes worth $472 million in Stericycle, Inc. (NASDAQ:SRCL), compared to 17 in the previous quarter worth $516 million.
Among the hedge funds being tracked by Insider Monkey, Chicago-based investment firm Ariel Investments is a leading shareholder in Stericycle, Inc. (NASDAQ:SRCL) with 4.2 million shares worth more than $253 million.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.